Prelude Therapeutics Incorporated
PRLDNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $326.65M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.16$6.83
- Volume (live)
- -
- Avg. volume (3M)
- 480.65K
Prelude Therapeutics Incorporated (PRLD) Stock Price & Financial Analysis
Prelude Therapeutics Incorporated Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $3.18 - $3.41 |
|---|---|
| 52-Week High | $6.83 |
| 52-Week Low | $1.16 |
| Open | $3.32 |
| Volume (last close) | 479.27K |
| Average Volume (3M) | 480.65K |
| Revenue (TTM) | 22.42M |
|---|---|
| Net Income (TTM) | -60.49M |
| Free Cash Flow (TTM) | -33.26M |
| EPS (TTM) | −$0.76 |
| Profit Margin | -269.75% |
| Operating Margin | -300.56% |
| Return on Equity (ROE) | -45.23% |
| Debt to Equity | 0.13 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 326.65M |
|---|---|
| Shares Outstanding | 98.39M |
| Price to Sales (P/S) | 14.57 |
| Price to Book (P/B) | 2.44 |
| EV/EBITDA | -5.34 |
| 50-Day MA | $4.86 |
|---|---|
| 200-Day MA | $3.95 |
| 1-Year Change | +178.99% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Prelude Therapeutics Incorporated at a Glance
As of the Oct 16, 2026 close, Prelude Therapeutics Incorporated (PRLD) has a market capitalization of $326.65M. The stock trades at 14.6× sales. Over the trailing twelve months it lost $60.49M on revenue of $22.42M and burned $33.26M of free cash flow. Revenue grew 220.3% year over year.
As of its latest reported balance sheet, it holds $26.33M in cash and securities against $17.65M of debt, a net cash position of $8.68M.
Prelude Therapeutics Incorporated does not currently pay a dividend.
The share price is up 179.0% over the past year. At $3.24 (the Oct 16, 2026 close) it sits within its 52-week range of $1.16 to $6.83, below its 200-day moving average of $3.95.
Based on 1 professional analyst rating from the past 90 days, the consensus is Buy.
Frequently Asked Questions About Prelude Therapeutics Incorporated
What is the current stock price for PRLD?
As of the Oct 16, 2026 close, PRLD stock trades at $3.24. The 52-week range is $1.16–$6.83, with a day range of $3.18–$3.41.
What is the P/E ratio for PRLD?
The P/E ratio (Price-to-Earnings) for PRLD is shown in the Key Statistics section. This valuation metric helps compare Prelude Therapeutics Incorporated to industry peers.
Does PRLD pay dividends?
Prelude Therapeutics Incorporated does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for PRLD?
Based on ratings from 1 professional analyst over the last 90 days, the consensus for PRLD is Buy.
What is the market cap of PRLD?
As of the Oct 16, 2026 close, Prelude Therapeutics Incorporated's market capitalization is $318.8M, classifying it as a small-cap company. Prelude Therapeutics Incorporated operates in the Healthcare sector within the Biotechnology industry.